P. Weiden, K. Sullivan, N. Flournoy, R. Storb, and E. Thomas, Antileukemic Effect of Chronic Graft-versus-Host Disease, New England Journal of Medicine, vol.304, issue.25, pp.1529-1562, 1981.
DOI : 10.1056/NEJM198106183042507

M. Horowitz, R. Gale, P. Sondel, J. Goldman, J. Kersey et al., Graft-versus-leukemia reactions after bone marrow transplantation, Blood, vol.75, pp.555-62, 1990.

H. Kolb, A. Schattenberg, J. Goldman, B. Hertenstein, N. Jacobsen et al., Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients, Blood, vol.86, pp.2041-50, 1995.

J. Gaschet, G. Gallot, C. Ibisch, A. Lim, J. Even et al., Erratum: Case Report: Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets, Bone Marrow Transplantation, vol.23, issue.12, pp.1327-1335, 1999.
DOI : 10.1038/sj.bmt.1701809

J. Gaschet, G. Gallot, C. Ibisch, A. Lim, J. Even et al., Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets, Bone Marrow Transplantation, vol.22, issue.4, pp.385-92, 1998.
DOI : 10.1038/sj.bmt.1701336

J. Gaschet, A. Lim, L. Liem, R. Vivien, M. Hallet et al., Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch., Journal of Clinical Investigation, vol.98, issue.1, pp.100-107, 1996.
DOI : 10.1172/JCI118753
URL : http://www.jci.org/articles/view/118753/files/pdf

J. Gaschet, B. Mahe, N. Milpied, M. Devilder, B. Dreno et al., Specificity of T cells invading the skin during acute graft-vs.-host disease after semiallogeneic bone marrow transplantation., Journal of Clinical Investigation, vol.91, issue.1, pp.12-20, 1993.
DOI : 10.1172/JCI116160
URL : http://www.jci.org/articles/view/116160/files/pdf

J. Gaschet, M. Trevino, M. Cherel, R. Vivien, A. Garcia-sahuquillo et al., HLA-target antigens and T-cell receptor diversity of activated T cells invading the skin during acute graft-versus-host disease, Blood, vol.87, pp.2345-53, 1996.

C. Ibisch, G. Gallot, R. Vivien, E. Diez, F. Jotereau et al., Recognition of leukemic blasts by HLA-DPB1-specific cytotoxic T cell clones: a perspective for adjuvant immunotherapy post-bone marrow transplantation, Bone Marrow Transplantation, vol.23, issue.11, pp.1153-1162, 1999.
DOI : 10.1038/sj.bmt.1701768
URL : http://www.nature.com/bmt/journal/v23/n11/pdf/1701768a.pdf

C. Rutten, S. Van-luxemburg-heijs, M. Griffioen, E. Marijt, I. Jedema et al., HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia, Leukemia, vol.25, issue.7, pp.1387-94, 2008.
DOI : 10.1016/0198-8859(94)00084-4
URL : http://www.nature.com/leu/journal/v22/n7/pdf/leu200890a.pdf

C. Rutten, S. Van-luxemburg-heijs, C. Halkes, C. Van-bergen, E. Marijt et al., Patient HLA-DP???Specific CD4+ T Cells from HLA-DPB1???Mismatched Donor Lymphocyte Infusion Can Induce Graft-versus-Leukemia Reactivity in the Presence or Absence of Graft-versus-Host Disease, Biology of Blood and Marrow Transplantation, vol.19, issue.1, pp.40-48, 2013.
DOI : 10.1016/j.bbmt.2012.07.020

B. Clemenceau, G. Gallot, F. Lemoine, D. Klatzmann, and H. Vie, Preparation of Genetically Homogeneous Antigen-Specific Thymidine Kinase Positive T-Lymphocyte Clones for the Control of Alloreactivity Post-Bone Marrow Transplantation, Human Gene Therapy, vol.15, issue.6, pp.542-52, 2004.
DOI : 10.1089/104303404323141999

B. Clemenceau, C. , N. Gallot, G. Vivien, R. Gaschet et al., Antibody-dependent cellular cytotoxicity (ADCC) is mediated by genetically modified antigen-specific human T lymphocytes, Blood, vol.107, issue.12, pp.4669-77, 2006.
DOI : 10.1182/blood-2005-09-3775
URL : http://www.bloodjournal.org/content/bloodjournal/107/12/4669.full.pdf

B. Clemenceau, S. Valsesia-wittmann, A. Jallas, R. Vivien, R. Rousseau et al., InVitro and InVivo comparison of lymphocytes transduced with a human CD16 or with a chimeric antigen receptor reveals potential off-target interactions due to the IgG2 CH2-CH3 CAR-spacer, J Immunol Res, vol.2015, p.482089, 2015.

Y. Hu and G. Smyth, ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays, Journal of Immunological Methods, vol.347, issue.1-2, pp.70-78, 2009.
DOI : 10.1016/j.jim.2009.06.008

C. Voorter, M. Groeneweg, M. Joannis, C. Meertens, F. Agis et al., Allele and haplotype frequencies of HLA-DPA1 and -DPB1 in the population of Guadeloupe, Tissue Antigens, vol.57, issue.Suppl 1, pp.147-53, 2014.
DOI : 10.1007/s00251-005-0043-8

A. Eljaafari, J. Van-snick, A. Voisin, F. Cormont, A. Farre et al., Alloreaction increases or restores CD40, CD54, and/or HLA molecule expression in acute myelogenous leukemia blasts, through secretion of inflammatory cytokines: dominant role for TNF??, in concert with IFN??, Leukemia, vol.77, issue.11, pp.1992-2001, 2006.
DOI : 10.1097/01.TP.0000101006.39475.41

N. Perrottet, C. Csajka, M. Pascual, O. Manuel, F. Lamoth et al., Population Pharmacokinetics of Ganciclovir in Solid-Organ Transplant Recipients Receiving Oral Valganciclovir, Antimicrobial Agents and Chemotherapy, vol.53, issue.7, pp.3017-3040, 2009.
DOI : 10.1128/AAC.00836-08
URL : http://aac.asm.org/content/53/7/3017.full.pdf

S. Riddell, K. Watanabe, J. Goodrich, C. Li, M. Agha et al., Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones, Science, vol.257, issue.5067, pp.238-279, 1992.
DOI : 10.1126/science.1352912

E. Walter, P. Greenberg, M. Gilbert, R. Finch, K. Watanabe et al., Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor, New England Journal of Medicine, vol.333, issue.16, pp.1038-1082, 1995.
DOI : 10.1056/NEJM199510193331603

H. Heslop, M. Brenner, C. Rooney, R. Krance, W. Roberts et al., Administration of Neomycin Resistance Gene Marked EBV Specific Cytotoxic T Lymphocytes to Recipients of Mismatched-Related or Phenotypically Similar Unrelated Donor Marrow Grafts. St. Jude Children's Research Hospital, Memphis, Tennesse, Human Gene Therapy, vol.5, issue.3, pp.381-97, 1994.
DOI : 10.1089/hum.1994.5.3-381

C. Rooney, C. Smith, C. Ng, S. Loftin, C. Li et al., Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation, The Lancet, vol.345, issue.8941, pp.9-13, 1995.
DOI : 10.1016/S0140-6736(95)91150-2

S. Rosenberg, B. Packard, P. Aebersold, D. Solomon, S. Topalian et al., Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma, New England Journal of Medicine, vol.319, issue.25, pp.1676-80, 1988.
DOI : 10.1056/NEJM198812223192527

S. Gill and C. June, Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies, Immunological Reviews, vol.99, issue.20 Pt 1, pp.68-89, 2015.
DOI : 10.3324/haematol.2013.100073

G. Gallot, S. Vollant, S. Saiagh, B. Clemenceau, R. Vivien et al., T-cell Therapy Using a Bank of EBV-specific Cytotoxic T Cells, Journal of Immunotherapy, vol.37, issue.3, pp.170-179, 2014.
DOI : 10.1097/CJI.0000000000000031
URL : https://hal.archives-ouvertes.fr/hal-01256575

T. Haque, G. Wilkie, M. Jones, C. Higgins, G. Urquhart et al., Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial, Blood, vol.110, issue.4, pp.1123-1154, 2007.
DOI : 10.1182/blood-2006-12-063008
URL : http://www.bloodjournal.org/content/bloodjournal/110/4/1123.full.pdf

J. Barker, E. Doubrovina, C. Sauter, J. Jaroscak, M. Perales et al., Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes, Blood, vol.116, issue.23, pp.5045-5054, 2010.
DOI : 10.1182/blood-2010-04-281873
URL : http://www.bloodjournal.org/content/bloodjournal/116/23/5045.full.pdf

A. Leen, C. Bollard, A. Mendizabal, E. Shpall, P. Szabolcs et al., Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation, Blood, vol.121, issue.26, pp.5113-5136, 2013.
DOI : 10.1182/blood-2013-02-486324
URL : http://www.bloodjournal.org/content/bloodjournal/121/26/5113.full.pdf

M. Vickers, G. Wilkie, N. Robinson, N. Rivera, T. Haque et al., Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease, British Journal of Haematology, vol.27, issue.3, pp.402-412, 2014.
DOI : 10.1097/00002371-200407000-00007

O. Reilly, R. Prockop, S. Hasan, A. Koehne, G. Doubrovina et al., Virus-specific T-cell banks for 'off the shelf' adoptive therapy of refractory infections, Bone Marrow Transplantation, vol.3, issue.9, pp.1163-72, 2016.
DOI : 10.1182/blood-2011-05-354449

C. Bollard and H. Heslop, T cells for viral infections after allogeneic hematopoietic stem cell transplant, Blood, vol.127, issue.26, pp.3331-3371, 2016.
DOI : 10.1182/blood-2016-01-628982
URL : http://www.bloodjournal.org/content/bloodjournal/127/26/3331.full.pdf

I. Tzannou, A. Papadopoulou, S. Naik, K. Leung, C. Martinez et al., Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation, Journal of Clinical Oncology, vol.35, issue.31, pp.3547-57, 2017.
DOI : 10.1200/JCO.2017.73.0655

G. Gallot, M. Hallet, J. Gaschet, J. Moreau, R. Vivien et al., Human HLA-specific T-cell clones with stable expression of a suicide gene: a possible tool to drive and control a graft-versus-host-graft-versus-leukemia reaction?, Blood, vol.88, pp.1098-103, 1996.

M. Mccarron, Y. Osborne, C. Story, J. Dempsey, D. Turner et al., Effect of age on lymphocyte proliferation, Mechanisms of Ageing and Development, vol.41, issue.3, pp.211-229, 1987.
DOI : 10.1016/0047-6374(87)90041-8

G. Pawelec, Y. Barnett, E. Mariani, and R. Solana, Human CD4+ T cell clone longevity in tissue culture: lack of influence of donor age or cell origin, Experimental Gerontology, vol.37, issue.2-3, pp.265-274, 2002.
DOI : 10.1016/S0531-5565(01)00192-9

B. Grubeck-loebenstein, H. Lechner, and K. Trieb, Long-Term in vitro Growth of Human T Cell Clones: Can Postmitotic ???Senescent??? Cell Populations Be Defined?, International Archives of Allergy and Immunology, vol.104, issue.3, pp.232-241, 1994.
DOI : 10.1159/000236671

L. Gattinoni, E. Lugli, Y. Ji, Z. Pos, C. Paulos et al., A human memory T cell subset with stem cell???like properties, Nature Medicine, vol.79, issue.10, pp.1290-1297, 2011.
DOI : 10.1002/cyto.a.21015
URL : http://europepmc.org/articles/pmc3192229?pdf=render

E. Wherry, V. Teichgraber, T. Becker, D. Masopust, S. Kaech et al., Lineage relationship and protective immunity of memory CD8 T cell subsets, Nature Immunology, vol.13, issue.3, pp.225-259, 2003.
DOI : 10.1016/S1074-7613(00)00029-7

P. Graef, V. Buchholz, C. Stemberger, M. Flossdorf, L. Henkel et al., Serial Transfer of Single-Cell-Derived Immunocompetence Reveals Stemness of CD8+ Central Memory T Cells, Immunity, vol.41, issue.1, pp.116-142, 2014.
DOI : 10.1016/j.immuni.2014.05.018
URL : https://doi.org/10.1016/j.immuni.2014.05.018

C. Yee, J. Thompson, D. Byrd, S. Riddell, P. Roche et al., Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells, Proceedings of the National Academy of Sciences, vol.71, issue.2, pp.16168-73, 2002.
DOI : 10.1002/(SICI)1097-0215(19970410)71:2<142::AID-IJC3>3.0.CO;2-0

A. Khammari, N. Labarriere, V. Vignard, J. Nguyen, M. Pandolfino et al., Treatment of Metastatic Melanoma with Autologous Melan-A/Mart-1-Specific Cytotoxic T Lymphocyte Clones, Journal of Investigative Dermatology, vol.129, issue.12, pp.2835-2877, 2009.
DOI : 10.1038/jid.2009.144
URL : https://doi.org/10.1038/jid.2009.144

J. Park, D. Digiusto, M. Slovak, C. Wright, A. Naranjo et al., Adoptive Transfer of Chimeric Antigen Receptor Re-directed Cytolytic T Lymphocyte Clones in Patients with Neuroblastoma, Molecular Therapy, vol.15, issue.4, pp.825-858, 2007.
DOI : 10.1038/sj.mt.6300104
URL : https://doi.org/10.1038/sj.mt.6300104

C. Georgiadis and W. Qasim, Emerging applications of gene edited T cells for the treatment of leukemia, Expert Review of Hematology, vol.10, issue.9, pp.753-55, 2017.
DOI : 10.1016/S0140-6736(14)61403-3

B. Berdien, U. Mock, D. Atanackovic, and B. Fehse, TALEN-mediated editing of endogenous T-cell receptors facilitates efficient reprogramming of T lymphocytes by lentiviral gene transfer, Gene Therapy, vol.969, issue.6, pp.539-587, 2014.
DOI : 10.1038/gt.2009.149

L. Poirot, B. Philip, C. Schiffer-mannioui, L. Clerre, D. Chion-sotinel et al., Multiplex Genome-Edited T-cell Manufacturing Platform for ???Off-the-Shelf??? Adoptive T-cell Immunotherapies, Cancer Research, vol.75, issue.18, pp.3853-64, 2015.
DOI : 10.1158/0008-5472.CAN-14-3321
URL : http://cancerres.aacrjournals.org/content/canres/75/18/3853.full.pdf

H. Torikai, A. Reik, F. Soldner, E. Warren, C. Yuen et al., Toward eliminating HLA class I expression to generate universal cells from allogeneic donors, Blood, vol.122, issue.8, pp.1341-1350, 2013.
DOI : 10.1182/blood-2013-03-478255
URL : http://www.bloodjournal.org/content/bloodjournal/122/8/1341.full.pdf